Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OM
SellSinkerOutset Medical, Inc. · Healthcare · United States · $74M · Avg Vol: $450K/d
23
StockRankGet insider-trade alerts
Q
35
V
42
M
33
P/E (TTM)
—
ROE
-59.2%
D/E
1.1x
Dividend %
—
COMPANY DESCRIPTION
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 115.4M | 130.4M | 113.7M | 119.5M | 1.2% | 117.8M | 126.0M | 139.1M | 7.9% |
| EPS | -8.84 | -9.45 | -7.03 | -5.37 | — | -3.80 | -3.09 | -2.29 | — |
| Shares | 18.5M | 18.5M | 18.5M | 18.2M | -2.0% | 18.8M | — | — | — |
| Debt | 103.2M | 136.2M | 201.9M | 101.2M | -0.6% | 104.4M | — | — | — |
| Equity | 246.0M | 122.9M | 26.8M | 127.0M | -19.8% | — | — | — | — |
| Op CF | -145.7M | -131.4M | -116.3M | -46.3M | — | -38.3M | — | — | — |
| Inv CF | -66.3M | 83.0M | 103.9M | -97.7M | — | — | — | — | — |
| Fin CF | 72.9M | 43.7M | 67.9M | 55.5M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-31.2%
SMA 50SMA 200
Close
$3.27
RSI (14)
12.4
52W High
$16.16
From 52W High
0.2%
SCORE BREAKDOWN
Quality
35
ROIC
-26.3%26.4
ROE
-59.2%15.8
GP/Assets
18.6%42.0
Op. Margin
-49.6%20.6
FCF/Assets
-14.7%25.3
Piotroski
783.9
Int. Cover
-4.3x28.0
D/E Ratio
1.08x12.5
Current Ratio
5.19x73.2
Value
42
P/E (TTM)
—N/A
EV/EBITDA
-0.4x25.0
P/FCF
—N/A
P/B
0.7x93.3
P/S
0.6x91.6
Div Yield
—N/A
Momentum
33
52W High %
20%3.4
RS 6M
-12%51.3
SMA 50/200
1.03x62.8
EPS Rev 4W
-5.0%13.5
EPS Rev 12W
—N/A
EPS Improve
+40%48.3
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$74M
P/E (Forward)
-1.6x
Gross Margin
41.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OM are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OM | Outset Medical, Inc.(you) | $74M | 23 | Sell |
| SRTS | Sensus Healthcare, Inc. | $58M | 22 | Sell |
| LNSR | LENSAR, Inc. | $102M | 22 | Sell |
| SERA | Sera Prognostics, Inc. | $82M | 14 | Strong Sell |
| ARAY | Accuray Incorporated | $53M | 19 | Strong Sell |
| LUNG | Pulmonx Corporation | $102M | 27 | Sell |
| MYO | Myomo, Inc. | $63M | 32 | Sell |
| ECOR | electroCore, Inc. | $87M | 33 | Sell |
| HYPR | Hyperfine, Inc. | $88M | 12 | Strong Sell |
| CVRX | CVRx, Inc. | $79M | 9 | Strong Sell |
Peer medians: ROE -30.2% · P/E 27.0x · Gross margin 58.3%